155 related articles for article (PubMed ID: 15727077)
1. Oral fluoropyrimidines in colorectal cancer: a door open to the future?
Delaunoit T; Neczyporenko F; Hendlisz A; Eisendrath P; Bleiberg H
Acta Gastroenterol Belg; 2004; 67(4):331-3. PubMed ID: 15727077
[TBL] [Abstract][Full Text] [Related]
2. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.
Benson AB
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):28-34. PubMed ID: 9830622
[TBL] [Abstract][Full Text] [Related]
3. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
4. Oral therapy for colorectal cancer: how to choose.
Damjanov N; Meropol NJ
Oncology (Williston Park); 2000 Jun; 14(6):799-807; discussion 807-8, 813-4,. PubMed ID: 10887632
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
6. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
[TBL] [Abstract][Full Text] [Related]
7. Practical considerations in the use of oral fluoropyrimidines.
Hoff PM
Semin Oncol; 2003 Jun; 30(3 Suppl 6):88-92. PubMed ID: 12802799
[TBL] [Abstract][Full Text] [Related]
8. Role of oral chemotherapy in colorectal cancer.
Donehower RC
Oncology (Williston Park); 2000 Nov; 14(11A):243-5. PubMed ID: 11195416
[TBL] [Abstract][Full Text] [Related]
9. Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer.
Cunningham D; James RD
Eur J Cancer; 2001 May; 37(7):826-34. PubMed ID: 11313169
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison.
Saif MW
Clin Colorectal Cancer; 2005 Jul; 5(2):89-100. PubMed ID: 16098249
[TBL] [Abstract][Full Text] [Related]
11. A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer.
Twelves C; Gollins S; Grieve R; Samuel L
Ann Oncol; 2006 Feb; 17(2):239-45. PubMed ID: 16344278
[TBL] [Abstract][Full Text] [Related]
12. Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?
Douillard JY; Bennouna J; Senellart H
Clin Colorectal Cancer; 2008 May; 7(3):206-11. PubMed ID: 18621641
[TBL] [Abstract][Full Text] [Related]
13. Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity.
Deboever G; Hiltrop N; Cool M; Lambrecht G
Clin Colorectal Cancer; 2013 Mar; 12(1):8-14. PubMed ID: 23102544
[TBL] [Abstract][Full Text] [Related]
14. Answering patients' needs: oral alternatives to intravenous therapy.
Borner M; Scheithauer W; Twelves C; Maroun J; Wilke H
Oncologist; 2001; 6 Suppl 4():12-6. PubMed ID: 11585969
[TBL] [Abstract][Full Text] [Related]
15. Oral fluoropyrimidines in colorectal cancer.
Van Cutsem E; Peeters M
Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
[No Abstract] [Full Text] [Related]
16. Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer.
Pfeiffer P; Mortensen JP; Bjerregaard B; Eckhoff L; Schønnemann K; Sandberg E; Aabo K; Jakobsen A
Eur J Cancer; 2006 Nov; 42(16):2738-43. PubMed ID: 17011184
[TBL] [Abstract][Full Text] [Related]
17. Oral fluoropyrimidine treatment of colorectal cancer.
Eng C; Kindler HL; Schilsky RL
Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
[TBL] [Abstract][Full Text] [Related]
18. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
[No Abstract] [Full Text] [Related]
19. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).
Hochster HS
Clin Adv Hematol Oncol; 2005 May; 3(5):405-6. PubMed ID: 16167014
[No Abstract] [Full Text] [Related]
20. Oral fluoropyrimidines: a closer look at their toxicities.
Macdonald JS
Am J Clin Oncol; 1999 Oct; 22(5):475-80. PubMed ID: 10521062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]